Skip to content
value.today
IMARA Inc. logo

IMARA Inc.

🇺🇸 Cambridge, Massachusetts, USAPharmaceuticalsFounded 2016
Total raised
$50 M
2 rounds on record
Latest round
$44 M
Mar 2019
First round on record
Apr 2016
Today
Went public
See the company page

IMARA Inc. is listed today as Enliven Therapeutics, Inc.: market value, financials and filings are on its company page.

Funding rounds

2 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of IMARA Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2024$90 MPrivate placement after listing$50 to $250 million

IMARA Inc.: Private sale, Mar 2024

Investors in this round

20 investors had bought by the notice of Apr 3, 2024: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 21 investors are named for IMARA Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$90 M of $90 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anish P. Patel · Executive Officer
  • Benjamin P. Hohl · Executive Officer
  • Helen P. Collins · Executive Officer
  • Joseph P. Lyssikatos · Executive Officer, Director
  • Samuel Kintz · Executive Officer, Director
  • Andrew P. Phillips · Director
  • Jake P. Bauer · Director
  • Mika P. Derynck · Director
  • Rahul P. Ballal · Director
  • Richard P. Heyman · Director
  • Rishi P. Gupta · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Benjamin Hohl, Chief Financial Officer. Source: SEC Form D, newest notice filed Apr 3, 2024. Read the notice at the SEC.

equity, optionsSEC
Mar 2019$44 MNo. 2$10 to $50 million

IMARA Inc.: Raise no. 2, Mar 2019

Investors in this round

11 investors had bought by the notice of Mar 29, 2019: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 21 investors are named for IMARA Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$44 M of $63 M offered; $19 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christoph M. Adams · Executive Officer
  • Rahul Ballal · Executive Officer, Director
  • Barbara G. Dalton · Director
  • Carl G. Goldfischer · Director
  • David G. Bonita · Director
  • David G. Mott · Director
  • James G. McArthur · Director
  • Mark G. Chin · Director
  • Mette Kirstine Agger · Director
  • Sara G. Nayeem · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Rahul Ballal, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 29, 2019. Read the notice at the SEC.

equitySEC
Apr 2016$6 MNo. 1$2 to $10 million

IMARA Inc.: Raise no. 1, Apr 2016

Investors in this round

7 investors had bought by the notice of Apr 21, 2016: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 21 investors are named for IMARA Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$6 M of $31 M offered; $25 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christoph M. Adams · Executive Officer, Director
  • James G. McArthur · Executive Officer, Director
  • Barbara Kirstine Dalton · Director
  • David Kirstine Mott · Director
  • Mette Kirstine Agger · Director
  • Robert M. Hopfner · Director
  • Sara Kirstine Nayeem · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James G. McArthur, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 21, 2016. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • IMARA Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2024).

    SEC Form D · Apr 2024

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Apr 2024

That is all the official record says: IMARA Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of IMARA Inc. are on record.

Investors#

21 named in official filings. Open an investor to see everything it has backed.

Investors in IMARA Inc.
InvestorKindAmountRoundRoleSource
Alexandria Venture Investments, LLCVenture capitalnot statednot statedHeld Series Seed, A and B preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Arix Bioscience Holdings LtdCompanynot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Arix Bioscience PLCCompanynot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Bay City Capital Fund V Co-Investment Fund, L.P.Fund or asset managernot statednot statedHeld Series Seed, A and B preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Bay City Capital Fund V, L.P.Fund or asset managernot statednot statedHeld Series Seed, A and B preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Bay City Capital LLCFund or asset managernot statednot statedHeld Series Seed, A and B preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Bay City Capital Management V LLCFund or asset managernot statednot statedHeld Series Seed, A and B preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Invest A/s LundbeckfondPersonnot statednot statedHeld Series Seed, A and B preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Lundbeck A. S. H.Personnot statednot statedHeld Series A preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Nea 14 GP, LTDCompanynot statednot statedHeld Series Seed, A and B preferred stock, 10% owner (Form 3, 2020)SEC Form 3
NEA Partners 14, L.P.Fund or asset managernot statednot statedHeld Series Seed, A and B preferred stock, 10% owner (Form 3, 2020)SEC Form 3
New Enterprise Associates 14, L.P.Fund or asset managernot statednot statedHeld Series Seed, A and B preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Orbimed Advisors LLCFund or asset managernot statednot statedHeld Series B preferred stock, 10% owner, director (Form 3, 2020)SEC Form 3
OrbiMed Capital GP VII LLCFund or asset managernot statednot statedHeld Series B preferred stock, 10% owner, director (Form 3, 2020)SEC Form 3
Pfizer IncFund or asset managernot statednot statedHeld Series Seed, A and B preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Pfizer Ventures (US) LLCVenture capitalnot statednot statedHeld Series Seed, A and B preferred stock, 10% owner (Form 3, 2020)SEC Form 3
RA Capital Healthcare Fund LPFund or asset managernot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Ra Capital Management, L.P.Fund or asset managernot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Rock Springs Capital LLCFund or asset managernot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Rock Springs Capital Management LPFund or asset managernot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Rock Springs Capital Master Fund LPFund or asset managernot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2020)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 11 investors.

Largest shareholders today

Institutions holding Enliven Therapeutics, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by IMARA Inc.
NameRoleNamed in
Anish P. PatelExecutive officerApr 2024
Benjamin P. HohlExecutive officerApr 2024
Helen P. CollinsExecutive officerApr 2024
Joseph P. LyssikatosExecutive officerApr 2024
Samuel KintzExecutive officerApr 2024
Christoph M. AdamsExecutive officerMar 2019
Rahul BallalExecutive officerMar 2019
James G. McArthurExecutive officerApr 2016
Andrew P. PhillipsDirectorApr 2024
Jake P. BauerDirectorApr 2024
Joseph P. LyssikatosDirectorApr 2024
Mika P. DerynckDirectorApr 2024
Rahul P. BallalDirectorApr 2024
Richard P. HeymanDirectorApr 2024
Rishi P. GuptaDirectorApr 2024
Samuel KintzDirectorApr 2024
Barbara G. DaltonDirectorMar 2019
Carl G. GoldfischerDirectorMar 2019
David G. BonitaDirectorMar 2019
David G. MottDirectorMar 2019
James G. McArthurDirectorMar 2019
Mark G. ChinDirectorMar 2019
Mette Kirstine AggerDirectorMar 2019
Rahul BallalDirectorMar 2019
Sara G. NayeemDirectorMar 2019
Barbara Kirstine DaltonDirectorApr 2016
Christoph M. AdamsDirectorApr 2016
David Kirstine MottDirectorApr 2016
Robert M. HopfnerDirectorApr 2016
Sara Kirstine NayeemDirectorApr 2016

Went public since 2020. Its SEC number is that of a company listed on a stock exchange.